Please note: AABB reserves the right to make updates to this program.
Live Program Date: February 5, 2019 -
Master Program Number: 18EL-362 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Hospitals, Hospital Blood Banks, Medical Directors, Nurses, Physicians, Residents/Fellow, Students (MD, MT, SBB), Transfusion Safety Officer
Teaching Level: Basic to Advanced
Director: Srijana Rajbhandary, BDS, MPH, Research and Data Analyst, AABB, Bethesda, MD
Moderator: Chester Andrzejewski, MD,PhD, FCAP, Medical Director, System Transfusion Medicine, Baystate Medical Center, Springfield, MA
Speakers: Chester Andrzejewski, MD, PhD, FCAP, Medical Director, System Transfusion Medicine, Baystate Medical Center, Springfield, MA; Jo Wiersum, MD, PhD, Transfusion and Transplantation Reactions in Patients (TRIP), Netherlands
After participating in this educational activity, participants should be able to:
- Describe the proposed changes to the definition of Transfusion-Associated Circulatory Overload (TACO) and the reasons these changes have been proposed.
- Describe the new TACO definition validation study results.
- Describe Transfusion- Associated Dyspnea (TAD) as a clinical entity.
- Describe TAD state of the research.
This program will include a review of the proposed revision to the ISBT definition of Transfusion-Associated Circulatory Overload (TACO), the justification for the changes, the potential impact and the results from the validation study. The program will highlight the transfusion associated adverse pulmonary sequelae. Participants will also learn about Transfusion-Associated Dyspnea (TAD) state of the research.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each to be eligible for 1.5 continuing education credits/contact hours for California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credits and credit types awarded for this program (live or on-demand) was determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage. Please note continuing medical education (CME) credit for Physicians is not available for this program.
Disclosures for the planners of this event can be found
here. Disclosures for the program faculty are provided at the beginning of the program.
Dr. Chester Andrzejewski is the Medical Director, System Transfusion Medicine at Baystate Medical Center. He is also the Assistant Professor of Pathology at the University of Massachusetts Medical School – Baystate and serves as the Adjunct Assistant Professor of Anatomic and Clinical Pathology at Tufts University School of Medicine.
Dr. Jo Wiersum obtained her medical degree in Leiden in 1981 and went on to work in the UK and the Republic of Guinea (West Africa). Since 1996 she has worked as a donor physician for the Dutch blood supply organisation, Sanquin. In 2000 she completed specialty training in community medicine. Since 2002 when the Dutch national hemovigilance office TRIP started, she has been its national medical coordinator. TRIP stands for Transfusion and Transplantation Reactions in Patients because it also handles reports on tissue and cell vigilance. Jo has chaired of the International Society for Blood Transfusion haemovigilance working party since 2011. In 2013 she obtained a PhD in medicine on a thesis entitled Hemovigilance: is it making a difference to safety in the transfusion chain.